Literature DB >> 15005728

RNA editing of interleukin-12 receptor beta2, 2451 C-to-U (Ala 604 Val) conversion, associated with atopy.

N Kondo1, E Matsui, H Kaneko, M Aoki, Z Kato, T Fukao, K Kasahara, N Morimoto.   

Abstract

BACKGROUND: The production of IgE in B lymphocytes is down-regulated by IFN-gamma. IL-12 induces IFN-gamma production by T lymphocytes and natural killer cells by binding to its specific receptor. RNA editing is a post-transcriptional modification.
OBJECTIVE: Here we show that the RNA editing of IL-12 receptor (R) beta2 is associated with atopy.
METHODS: Atopic patients and non-atopic healthy controls were studied. Fragments of IL-12R beta2 cDNA and genomic DNA were amplified and sequenced. Furthermore, the function of the IL-12R beta2 chain was investigated.
RESULTS: Sequence analysis of the cDNA clones representing IL-12R beta2 mRNA transcripts revealed a C-to-U conversion at nucleotide 2451 (Ala 604 Val) on exon 13 in some atopic patients. Surprisingly, sequence analysis of their genomic DNA showed no 2451 C-to-T (Ala 604 Val) mutation. We concluded that the observed C-to-U mismatch in the cDNA clone is due to a post-transcriptional modification, RNA editing. The C-to-U conversion was observed in 21 (20.6%) of 102 atopic patients, whereas this conversion was observed in only 4 (3.8%) of 104 non-atopic subjects (P<0.001). IFN-gamma production by peripheral blood mononuclear cells (PBMCs) stimulated with IL-12 in the subjects with the C-to-U conversion was significantly lower than that in the subjects without the C-to-U conversion. In atopic patients with the C-to-U conversion, PBMCs faintly showed the tyrosine phosphorylation of Stat4, and the IgE production by PBMCs was not suppressed by IL-12 whereas it was suppressed by IFN-gamma.
CONCLUSIONS: The RNA editing of IL-12R beta2, 2451 C-to-U (Ala 604 Val) conversion causes impairment of the IL-12 signal cascade and the subsequent reduction in IFN-gamma production, resulting in the impaired down-regulation of IgE production. This is the first report indicating that atopy is associated with RNA editing.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15005728     DOI: 10.1111/j.1365-2222.2004.01901.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  4 in total

1.  A survey of RNA editing in human brain.

Authors:  Matthew Blow; P Andrew Futreal; Richard Wooster; Michael R Stratton
Journal:  Genome Res       Date:  2004-11-15       Impact factor: 9.043

Review 2.  When you can't trust the DNA: RNA editing changes transcript sequences.

Authors:  Volker Knoop
Journal:  Cell Mol Life Sci       Date:  2010-10-12       Impact factor: 9.261

3.  Glutathione reaction products with a chemical allergen, methylene-diphenyl diisocyanate, stimulate alternative macrophage activation and eosinophilic airway inflammation.

Authors:  Adam V Wisnewski; Jian Liu; Christopher M Colangelo
Journal:  Chem Res Toxicol       Date:  2015-02-18       Impact factor: 3.739

4.  mRNA expression and RNA editing (2451 C-to-U) of IL-12 receptor beta2 in adult atopic patients.

Authors:  Eun Jin Kim; Won Mok Lee; Jung Sook Ha; Nam Hee Ryoo; Dong Suk Jeon; Jae Ryong Kim
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.